Evidence map›Paper›PMID 30559135›Full record

ArticleAntimicrobial agents and chemotherapy2019

Emergence of OXA-232 Carbapenemase-Producing

Lingbin Shu, Ning Dong, Jun Lu, Zhiwei Zheng, Jie Hu, Wenqing Zeng, Qiaoling Sun, Edward Wai-Chi Chan, Hongwei Zhou, Fupin Hu and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. A systematic review of hypervirulentFrontiers in medicine · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Exploring current hypervirulentFrontiers in microbiology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Carbapenem-resistantJAC-antimicrobial resistance · 2024
    Article
  12. Article
  13. HypervirulentPathogens & immunity · 2024
    Review
  14. Molecular epidemiology of multidrug-resistantFrontiers in cellular and infection microbiology · 2024
    Article
  15. Characterization of ST15-KL112Infection and drug resistance · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Lingbin Shu *Department of Clinical Laboratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Ning Dong *Shenzhen Key Lab for Food Biological Safety Control, Food Safety and Technology Research Center, Hong Kong PolyU Shen Zhen Research Institute, Shenzhen, China.ORCID 0000-0001-6515-4201
Jun LuThe Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Zhiwei ZhengShenzhen Key Lab for Food Biological Safety Control, Food Safety and Technology Research Center, Hong Kong PolyU Shen Zhen Research Institute, Shenzhen, China.
Jie HuDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Wenqing ZengThe Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Qiaoling SunDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Edward Wai-Chi ChanShenzhen Key Lab for Food Biological Safety Control, Food Safety and Technology Research Center, Hong Kong PolyU Shen Zhen Research Institute, Shenzhen, China.
Hongwei ZhouDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Fupin HuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Sheng ChenShenzhen Key Lab for Food Biological Safety Control, Food Safety and Technology Research Center, Hong Kong PolyU Shen Zhen Research Institute, Shenzhen, China sheng.chen@polyu.edu.hk zhang-rong@zju.edu.cn.
Rong ZhangDepartment of Clinical Laboratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China sheng.chen@polyu.edu.hk zhang-rong@zju.edu.cn.
Second Affiliated Hospital of Zhejiang University · CNHong Kong Polytechnic University · HKZhejiang Chinese Medical University · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study reported the clonal dissemination of OXA-232-producing sequence type 15 (ST15) carbapenem-resistant

Indexed as

AgedAged, 80 and overAnti-Bacterial AgentsBase Sequencebeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeChinaDrug Resistance, Multiple, BacterialHumansImmunocompromised HostKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsPlasmidsSequence Analysis, DNAVirulenceAnti-Bacterial Agentsbeta-lactamase OXA-232, Klebsiella pneumoniaebeta-Lactamasesclonal spreadKlebsiella pneumoniaeOXA-232virulence plasmidvirulence potential

Identifiers

PMID30559135
PMCPMC6395905
OpenAlexW2905301530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.